Zivo Bioscience stock analysis
Want to see ZIVO full AI Analyst Report?
Zivo Bioscience (ZIVO) Stock Price & Analysis
ZIVO Stock Chart & Stats
- Day’s Range
- $5.16 - $5.99
- 52-Week Range
- $1.11 - $12.50
- Previous Close
- $5.76
- Volume
- N/A
- Average Volume (3M)
- 557
- Market Cap
- $21.39M
- Enterprise Value
- $14.92T
- Total Cash (Recent Filing)
- $5,249
- Total Debt (Recent Filing)
- $612.53K
- Price to Earnings (P/E)
- ―
- Beta
- 0.47
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth
The significant revenue growth trajectory indicates strong demand for Zivo's algal bioactive compounds, supporting long-term market potential and business expansion.
Business Model
The licensing and partnership-based business model allows Zivo to leverage its intellectual property, providing scalable revenue streams and reducing operational risks.
Market Position
Operating across multiple high-growth sectors diversifies Zivo's market exposure, enhancing resilience against sector-specific downturns and supporting sustainable growth.
Bears Say
Financial Instability
Negative equity and insolvency highlight severe financial instability, threatening Zivo's operational continuity and necessitating immediate restructuring for long-term viability.
Cash Flow Issues
Persistent negative cash flow undermines liquidity and limits Zivo's ability to invest in growth opportunities, posing a significant risk to its financial health and strategic initiatives.
Profitability Challenges
Ongoing net losses and negative profit margins indicate operational inefficiencies and a lack of profitability, challenging Zivo's ability to achieve sustainable financial performance.
ZIVO FAQ
What was Zivo Bioscience’s price range in the past 12 months?
What is Zivo Bioscience’s market cap?
When is Zivo Bioscience’s upcoming earnings report date?
How were Zivo Bioscience’s earnings last quarter?
Is Zivo Bioscience overvalued?
Does Zivo Bioscience pay dividends?
What is Zivo Bioscience’s EPS estimate?
How many shares outstanding does Zivo Bioscience have?
What happened to Zivo Bioscience’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Zivo Bioscience?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Zivo Bioscience
ZIVO Bioscience, Inc. is a research and development firm that specializes in the creation and commercialization of natural bioactive compounds. These unique ingredients, derived from its proprietary algae cultures, are licensed and sold to manufacturers producing goods for animal health, human consumption, dietary supplements, and medical foods. The company operates at the intersection of biotechnology and agricultural technology, boasting a comprehensive intellectual property portfolio. This includes distinct algal and bacterial strains, advanced biologically active molecules and complexes, innovative production and cultivation techniques, and various inventions, some patented and others pending approval, all geared towards improving human and animal well-being. Its product applications are broad, addressing areas such as promoting gut health in poultry, combating bovine mastitis, improving joint function in canines, modulating the human immune system, providing algal biomass for direct human consumption, and offering biomass-based solutions for skin care and anti-aging. Founded originally as Health Enhancement Products, Inc., the company officially rebranded to ZIVO Bioscience, Inc. in October 2014. Its corporate operations are based in Bloomfield Hills, Michigan.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- John Bernard Payne
- Employees
- 7
- Website
- www.zivobioscience.com
- Address
- 2125 Butterfield Drive, Troy, MI, 48084, US
Zivo Bioscience (ZIVO) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 8 | 3 | 11 |
| Technical Analysis | 4 | 3 | 3 |
| Moving Averages | 4 | 0 | 8 |











